Capecitabine/Cisplatin/Tislelizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of capecitabine, cisplatin, and tislelizumab that may be used in the treatment of esophageal and esophagogastric junction cancers, and gastric cancer.

**Synonyms:** - Capecitabine-Cisplatin-Tislelizumab - Capecitabine/Cisplatin Plus Tislelizumab-jsgr - Capecitabine/Cisplatin/Tevimbra - Capecitabine/Cisplatin/Tislelizumab - Capecitabine/Cisplatin/Tislelizumab-jsgr Regimen